Log In
Print
BCIQ
Print
Print this Print this
 

LFG316

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionHuman HuCAL antibody against complement 5 (C5)
Molecular Target Complement 5 (C5)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today